Trials and Tribulations of Electronic Patient Consent: Removing Barriers to eConsent Adoption

Register free: http://www.appliedclinicaltrialsonline.com/act_w/econsent

​Event Overview:

The COVID-19 pandemic has permanently changed the trajectory of decentralized trials and electronic patient informed consent (eConsent) solutions. After a decade of dabbling with eConsent, how can sponsors and technology providers meet the demand to bring clinical trials directly to the patient at a global scale?

Join this webcast to hear the hard-fought advances in eConsent maturity, as small-scale experimentation turned abruptly into massive rollouts. You’ll learn strategies to employ to overcome the persistent challenges in eConsent adoption and gain the benefits promised from successful decentralized trials with remote capabilities for patients and sites.

3 Key take-aways:

1. Understand the barriers to wide-scale eConsent adoption and how they’ve changed from pre-pandemic to today
2. Learn why connecting eConsent to the entire trial experience is so important to site satisfaction, study operations, and sponsor oversight
3. Hear about the launch of IQVIA Complete Consent, the next generation of eConsent solutions that eliminates every major barrier to deploying eConsent at scale and more

Speaker: Peter Hassett, Director of Strategy, Patient Consent, IQVIA Technologies (formerly DrugDev)

Time and Date: Wednesday, April 28, 2021 at 11am EDT

On demand available after final airing until Apr. 28, 2022

Register free: http://www.appliedclinicaltrialsonline.com/act_w/econsent